|
1 Indications And Usage Tobi Is Indicated For The Management Of Cystic Fibrosis In Adults And Pediatric Patients 6 Years Of Age And Older With Pseudomonas Aeruginosa . Safety And Efficacy Have Not Been Demonstrated In Patients Under The Age Of 6 Years, Patients With Forced Expiratory Volume In 1 Second (Fev 1 ) < 25% Or > 75% Predicted, Or Patients Colonized With Burkholderia Cepacia [See Clinical Studies (14) ]. Tobi Is An Aminoglycoside Antibacterial Indicated For The Management Of Cystic Fibrosis In Adults And Pediatric Patients 6 Years Of Age And Older With Pseudomonas Aeruginosa . Safety And Efficacy Have Not Been Demonstrated In Patients Under The Age Of 6 Years, Patients With Forced Expiratory Volume In 1 Second (Fev 1 ) < 25% Or > 75% Predicted, Or Patients Colonized With Burkholderia Cepacia .
|